Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Biron

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
The American Journal of Medicine|July 20, 1982
Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virusJ A Fyfe, K K Biron, S A McKee, et al.
Annals of Internal Medicine|July 1, 1991
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infectionS Safrin, T G Berger, I Gilson, et al.
Antiviral Chemistry & Chemotherapy|January 6, 2001
Differences in DNA packaging genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and TowneP M Krosky, R G Ptak, M R Underwood, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivativesV Sullivan, K K Biron, C Talarico, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virusP de Miranda, T C Burnette, K K Biron, et al.
Journal of Virology|March 1, 1996
Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDSF Baldanti, M R Underwood, S C Stanat, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virusG W Koszalka, D R Averett, J A Fyfe, et al.
Annals of Internal Medicine|February 1, 1990
Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS)M A Jacobson, T G Berger, S Fikrig, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphateK K Biron, J A Fyfe, S C Stanat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1985
Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirusK K Biron, S C Stanat, J B Sorrell, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
The American Journal of Medicine|July 20, 1982
Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virusJ A Fyfe, K K Biron, S A McKee, et al.
Annals of Internal Medicine|July 1, 1991
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infectionS Safrin, T G Berger, I Gilson, et al.
Antiviral Chemistry & Chemotherapy|January 6, 2001
Differences in DNA packaging genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and TowneP M Krosky, R G Ptak, M R Underwood, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivativesV Sullivan, K K Biron, C Talarico, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virusP de Miranda, T C Burnette, K K Biron, et al.
Journal of Virology|March 1, 1996
Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDSF Baldanti, M R Underwood, S C Stanat, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virusG W Koszalka, D R Averett, J A Fyfe, et al.
Annals of Internal Medicine|February 1, 1990
Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS)M A Jacobson, T G Berger, S Fikrig, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphateK K Biron, J A Fyfe, S C Stanat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1985
Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirusK K Biron, S C Stanat, J B Sorrell, et al.
Pageof 8